ArriVent BioPharma, Inc. - AVBP
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 04, 2026 | Chief Operating Officer | A | A | 130,000.0 | 0.0 | 0.0 | 130,000.0 | View | |
| Feb 04, 2026 | President of R&D | A | A | 150,000.0 | 0.0 | 0.0 | 150,000.0 | View | |
| Feb 04, 2026 | Chief Financial Officer | A | A | 140,000.0 | 0.0 | 0.0 | 140,000.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 550,000.0 | 0.0 | 0.0 | 550,000.0 | View | |
| Feb 04, 2026 | General Counsel | A | A | 130,000.0 | 0.0 | 0.0 | 130,000.0 | View | |
| Feb 03, 2026 | — | S | D | 555,555.0 | 23.37 | 12,983,320.35 | 3,929,117.0 | View |